aluates Reports

$ 0.0

Automative

Global Preclinical CRO Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-33R1728

Global Preclinical CRO Treatment Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Preclinical CRO Treatment Market Research Report 2025

Code: QYRE-Auto-33R1728

Report

September 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Charles River Laboratories

Laboratory Corporation of America

Envigo

Eurofins Scientific

PRA Health Science

Medpace

Pharmaceutical Product Development

Paraxel

Wuxi Apptec Co.,Ltd.

Pharmaron

Joinn Laboratories

Medicilon

Crown Bioscience

Yinuosi Bio-Technology

Preclinical CRO Treatment Market Size

The global market for Preclinical CRO Treatment was valued at US$ 897 million in the year 2024 and is projected to reach a revised size of US$ 1986 million by 2031, growing at a CAGR of 12.2% during the forecast period.

Preclinical CRO Treatment Market

Preclinical contract research organizations (CROs) offer research and development services to pharmaceutical and biotechnology companies during the early stages of drug development, including preclinical studies and animal testing.

The market for preclinical CRO services is driven by the demand for specialized expertise and resources in drug development and the need for efficient and cost-effective preclinical research. The market"s growth is also influenced by the increasing outsourcing of preclinical studies by pharmaceutical and biotech companies.

This report aims to provide a comprehensive presentation of the global market for Preclinical CRO Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical CRO Treatment.

The Preclinical CRO Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Preclinical CRO Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Preclinical CRO Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Preclinical CRO Treatment Market Report

Report Metric	Details
Report Name	Preclinical CRO Treatment Market
Accounted market size in year	US$ 897 million
Forecasted market size in 2031	US$ 1986 million
CAGR	12.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Bioanalysis and DMPK Studies Toxicology Testing
Segment by Application	Biopharmaceutical Companies Government and Academic Institutes Medical Device Companies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Charles River Laboratories, Laboratory Corporation of America, Envigo, Eurofins Scientific, PRA Health Science, Wuxi Apptec Co.,Ltd., Medpace, Pharmaceutical Product Development, Paraxel, Pharmaron, Joinn Laboratories, Medicilon Inc., Crown Bioscience, Yinuosi Bio-Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical CRO Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Preclinical CRO Treatment Market growing?

Ans: The Preclinical CRO Treatment Market witnessing a CAGR of 12.2% during the forecast period 2025-2031.

What is the Preclinical CRO Treatment Market size in 2031?

Ans: The Preclinical CRO Treatment Market size in 2031 will be US$ 1986 million.

Who are the main players in the Preclinical CRO Treatment Market report?

Ans: The main players in the Preclinical CRO Treatment Market are Charles River Laboratories, Laboratory Corporation of America, Envigo, Eurofins Scientific, PRA Health Science, Wuxi Apptec Co.,Ltd., Medpace, Pharmaceutical Product Development, Paraxel, Pharmaron, Joinn Laboratories, Medicilon Inc., Crown Bioscience, Yinuosi Bio-Technology

What are the Application segmentation covered in the Preclinical CRO Treatment Market report?

Ans: The Applications covered in the Preclinical CRO Treatment Market report are Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies

What are the Type segmentation covered in the Preclinical CRO Treatment Market report?

Ans: The Types covered in the Preclinical CRO Treatment Market report are Bioanalysis and DMPK Studies, Toxicology Testing

Recommended Reports

CRO Services Market

Preclinical CRO Analysis

Drug & Therapy Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Preclinical CRO Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Bioanalysis and DMPK Studies

1.2.3 Toxicology Testing

1.3 Market by Application

1.3.1 Global Preclinical CRO Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Biopharmaceutical Companies

1.3.3 Government and Academic Institutes

1.3.4 Medical Device Companies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Preclinical CRO Treatment Market Perspective (2020-2031)

2.2 Global Preclinical CRO Treatment Growth Trends by Region

2.2.1 Global Preclinical CRO Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Preclinical CRO Treatment Historic Market Size by Region (2020-2025)

2.2.3 Preclinical CRO Treatment Forecasted Market Size by Region (2026-2031)

2.3 Preclinical CRO Treatment Market Dynamics

2.3.1 Preclinical CRO Treatment Industry Trends

2.3.2 Preclinical CRO Treatment Market Drivers

2.3.3 Preclinical CRO Treatment Market Challenges

2.3.4 Preclinical CRO Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Preclinical CRO Treatment Players by Revenue

3.1.1 Global Top Preclinical CRO Treatment Players by Revenue (2020-2025)

3.1.2 Global Preclinical CRO Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Preclinical CRO Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Preclinical CRO Treatment Revenue

3.4 Global Preclinical CRO Treatment Market Concentration Ratio

3.4.1 Global Preclinical CRO Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Treatment Revenue in 2024

3.5 Global Key Players of Preclinical CRO Treatment Head office and Area Served

3.6 Global Key Players of Preclinical CRO Treatment, Product and Application

3.7 Global Key Players of Preclinical CRO Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Preclinical CRO Treatment Breakdown Data by Type

4.1 Global Preclinical CRO Treatment Historic Market Size by Type (2020-2025)

4.2 Global Preclinical CRO Treatment Forecasted Market Size by Type (2026-2031)

5 Preclinical CRO Treatment Breakdown Data by Application

5.1 Global Preclinical CRO Treatment Historic Market Size by Application (2020-2025)

5.2 Global Preclinical CRO Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Preclinical CRO Treatment Market Size (2020-2031)

6.2 North America Preclinical CRO Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Preclinical CRO Treatment Market Size by Country (2020-2025)

6.4 North America Preclinical CRO Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Preclinical CRO Treatment Market Size (2020-2031)

7.2 Europe Preclinical CRO Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Preclinical CRO Treatment Market Size by Country (2020-2025)

7.4 Europe Preclinical CRO Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Preclinical CRO Treatment Market Size (2020-2031)

8.2 Asia-Pacific Preclinical CRO Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Preclinical CRO Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Preclinical CRO Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Preclinical CRO Treatment Market Size (2020-2031)

9.2 Latin America Preclinical CRO Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Preclinical CRO Treatment Market Size by Country (2020-2025)

9.4 Latin America Preclinical CRO Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Preclinical CRO Treatment Market Size (2020-2031)

10.2 Middle East & Africa Preclinical CRO Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Preclinical CRO Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Preclinical CRO Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Charles River Laboratories

11.1.1 Charles River Laboratories Company Details

11.1.2 Charles River Laboratories Business Overview

11.1.3 Charles River Laboratories Preclinical CRO Treatment Introduction

11.1.4 Charles River Laboratories Revenue in Preclinical CRO Treatment Business (2020-2025)

11.1.5 Charles River Laboratories Recent Development

11.2 Laboratory Corporation of America

11.2.1 Laboratory Corporation of America Company Details

11.2.2 Laboratory Corporation of America Business Overview

11.2.3 Laboratory Corporation of America Preclinical CRO Treatment Introduction

11.2.4 Laboratory Corporation of America Revenue in Preclinical CRO Treatment Business (2020-2025)

11.2.5 Laboratory Corporation of America Recent Development

11.3 Envigo

11.3.1 Envigo Company Details

11.3.2 Envigo Business Overview

11.3.3 Envigo Preclinical CRO Treatment Introduction

11.3.4 Envigo Revenue in Preclinical CRO Treatment Business (2020-2025)

11.3.5 Envigo Recent Development

11.4 Eurofins Scientific

11.4.1 Eurofins Scientific Company Details

11.4.2 Eurofins Scientific Business Overview

11.4.3 Eurofins Scientific Preclinical CRO Treatment Introduction

11.4.4 Eurofins Scientific Revenue in Preclinical CRO Treatment Business (2020-2025)

11.4.5 Eurofins Scientific Recent Development

11.5 PRA Health Science

11.5.1 PRA Health Science Company Details

11.5.2 PRA Health Science Business Overview

11.5.3 PRA Health Science Preclinical CRO Treatment Introduction

11.5.4 PRA Health Science Revenue in Preclinical CRO Treatment Business (2020-2025)

11.5.5 PRA Health Science Recent Development

11.6 Wuxi Apptec Co.,Ltd.

11.6.1 Wuxi Apptec Co.,Ltd. Company Details

11.6.2 Wuxi Apptec Co.,Ltd. Business Overview

11.6.3 Wuxi Apptec Co.,Ltd. Preclinical CRO Treatment Introduction

11.6.4 Wuxi Apptec Co.,Ltd. Revenue in Preclinical CRO Treatment Business (2020-2025)

11.6.5 Wuxi Apptec Co.,Ltd. Recent Development

11.7 Medpace

11.7.1 Medpace Company Details

11.7.2 Medpace Business Overview

11.7.3 Medpace Preclinical CRO Treatment Introduction

11.7.4 Medpace Revenue in Preclinical CRO Treatment Business (2020-2025)

11.7.5 Medpace Recent Development

11.8 Pharmaceutical Product Development

11.8.1 Pharmaceutical Product Development Company Details

11.8.2 Pharmaceutical Product Development Business Overview

11.8.3 Pharmaceutical Product Development Preclinical CRO Treatment Introduction

11.8.4 Pharmaceutical Product Development Revenue in Preclinical CRO Treatment Business (2020-2025)

11.8.5 Pharmaceutical Product Development Recent Development

11.9 Paraxel

11.9.1 Paraxel Company Details

11.9.2 Paraxel Business Overview

11.9.3 Paraxel Preclinical CRO Treatment Introduction

11.9.4 Paraxel Revenue in Preclinical CRO Treatment Business (2020-2025)

11.9.5 Paraxel Recent Development

11.10 Pharmaron

11.10.1 Pharmaron Company Details

11.10.2 Pharmaron Business Overview

11.10.3 Pharmaron Preclinical CRO Treatment Introduction

11.10.4 Pharmaron Revenue in Preclinical CRO Treatment Business (2020-2025)

11.10.5 Pharmaron Recent Development

11.11 Joinn Laboratories

11.11.1 Joinn Laboratories Company Details

11.11.2 Joinn Laboratories Business Overview

11.11.3 Joinn Laboratories Preclinical CRO Treatment Introduction

11.11.4 Joinn Laboratories Revenue in Preclinical CRO Treatment Business (2020-2025)

11.11.5 Joinn Laboratories Recent Development

11.12 Medicilon Inc.

11.12.1 Medicilon Inc. Company Details

11.12.2 Medicilon Inc. Business Overview

11.12.3 Medicilon Inc. Preclinical CRO Treatment Introduction

11.12.4 Medicilon Inc. Revenue in Preclinical CRO Treatment Business (2020-2025)

11.12.5 Medicilon Inc. Recent Development

11.13 Crown Bioscience

11.13.1 Crown Bioscience Company Details

11.13.2 Crown Bioscience Business Overview

11.13.3 Crown Bioscience Preclinical CRO Treatment Introduction

11.13.4 Crown Bioscience Revenue in Preclinical CRO Treatment Business (2020-2025)

11.13.5 Crown Bioscience Recent Development

11.14 Yinuosi Bio-Technology

11.14.1 Yinuosi Bio-Technology Company Details

11.14.2 Yinuosi Bio-Technology Business Overview

11.14.3 Yinuosi Bio-Technology Preclinical CRO Treatment Introduction

11.14.4 Yinuosi Bio-Technology Revenue in Preclinical CRO Treatment Business (2020-2025)

11.14.5 Yinuosi Bio-Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Charles River Laboratories

Laboratory Corporation of America

Envigo

Eurofins Scientific

PRA Health Science

Medpace

Pharmaceutical Product Development

Paraxel

Wuxi Apptec Co.,Ltd.

Pharmaron

Joinn Laboratories

Medicilon

Crown Bioscience

Yinuosi Bio-Technology

List of Tables

Table 1. Global Preclinical CRO Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Bioanalysis and DMPK Studies

Table 3. Key Players of Toxicology Testing

Table 4. Global Preclinical CRO Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Preclinical CRO Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Preclinical CRO Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Preclinical CRO Treatment Market Share by Region (2020-2025)

Table 8. Global Preclinical CRO Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Preclinical CRO Treatment Market Share by Region (2026-2031)

Table 10. Preclinical CRO Treatment Market Trends

Table 11. Preclinical CRO Treatment Market Drivers

Table 12. Preclinical CRO Treatment Market Challenges

Table 13. Preclinical CRO Treatment Market Restraints

Table 14. Global Preclinical CRO Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Preclinical CRO Treatment Market Share by Players (2020-2025)

Table 16. Global Top Preclinical CRO Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO Treatment as of 2024)

Table 17. Ranking of Global Top Preclinical CRO Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Preclinical CRO Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Preclinical CRO Treatment, Headquarters and Area Served

Table 20. Global Key Players of Preclinical CRO Treatment, Product and Application

Table 21. Global Key Players of Preclinical CRO Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Preclinical CRO Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Preclinical CRO Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Preclinical CRO Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Preclinical CRO Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Preclinical CRO Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Preclinical CRO Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Preclinical CRO Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Preclinical CRO Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Preclinical CRO Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Preclinical CRO Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Preclinical CRO Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Preclinical CRO Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Preclinical CRO Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Preclinical CRO Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Preclinical CRO Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Preclinical CRO Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Preclinical CRO Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Preclinical CRO Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Preclinical CRO Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Preclinical CRO Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Preclinical CRO Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Preclinical CRO Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Preclinical CRO Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Charles River Laboratories Company Details

Table 47. Charles River Laboratories Business Overview

Table 48. Charles River Laboratories Preclinical CRO Treatment Product

Table 49. Charles River Laboratories Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 50. Charles River Laboratories Recent Development

Table 51. Laboratory Corporation of America Company Details

Table 52. Laboratory Corporation of America Business Overview

Table 53. Laboratory Corporation of America Preclinical CRO Treatment Product

Table 54. Laboratory Corporation of America Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 55. Laboratory Corporation of America Recent Development

Table 56. Envigo Company Details

Table 57. Envigo Business Overview

Table 58. Envigo Preclinical CRO Treatment Product

Table 59. Envigo Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 60. Envigo Recent Development

Table 61. Eurofins Scientific Company Details

Table 62. Eurofins Scientific Business Overview

Table 63. Eurofins Scientific Preclinical CRO Treatment Product

Table 64. Eurofins Scientific Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 65. Eurofins Scientific Recent Development

Table 66. PRA Health Science Company Details

Table 67. PRA Health Science Business Overview

Table 68. PRA Health Science Preclinical CRO Treatment Product

Table 69. PRA Health Science Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 70. PRA Health Science Recent Development

Table 71. Wuxi Apptec Co.,Ltd. Company Details

Table 72. Wuxi Apptec Co.,Ltd. Business Overview

Table 73. Wuxi Apptec Co.,Ltd. Preclinical CRO Treatment Product

Table 74. Wuxi Apptec Co.,Ltd. Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 75. Wuxi Apptec Co.,Ltd. Recent Development

Table 76. Medpace Company Details

Table 77. Medpace Business Overview

Table 78. Medpace Preclinical CRO Treatment Product

Table 79. Medpace Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 80. Medpace Recent Development

Table 81. Pharmaceutical Product Development Company Details

Table 82. Pharmaceutical Product Development Business Overview

Table 83. Pharmaceutical Product Development Preclinical CRO Treatment Product

Table 84. Pharmaceutical Product Development Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 85. Pharmaceutical Product Development Recent Development

Table 86. Paraxel Company Details

Table 87. Paraxel Business Overview

Table 88. Paraxel Preclinical CRO Treatment Product

Table 89. Paraxel Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 90. Paraxel Recent Development

Table 91. Pharmaron Company Details

Table 92. Pharmaron Business Overview

Table 93. Pharmaron Preclinical CRO Treatment Product

Table 94. Pharmaron Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 95. Pharmaron Recent Development

Table 96. Joinn Laboratories Company Details

Table 97. Joinn Laboratories Business Overview

Table 98. Joinn Laboratories Preclinical CRO Treatment Product

Table 99. Joinn Laboratories Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 100. Joinn Laboratories Recent Development

Table 101. Medicilon Inc. Company Details

Table 102. Medicilon Inc. Business Overview

Table 103. Medicilon Inc. Preclinical CRO Treatment Product

Table 104. Medicilon Inc. Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 105. Medicilon Inc. Recent Development

Table 106. Crown Bioscience Company Details

Table 107. Crown Bioscience Business Overview

Table 108. Crown Bioscience Preclinical CRO Treatment Product

Table 109. Crown Bioscience Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 110. Crown Bioscience Recent Development

Table 111. Yinuosi Bio-Technology Company Details

Table 112. Yinuosi Bio-Technology Business Overview

Table 113. Yinuosi Bio-Technology Preclinical CRO Treatment Product

Table 114. Yinuosi Bio-Technology Revenue in Preclinical CRO Treatment Business (2020-2025) & (US$ Million)

Table 115. Yinuosi Bio-Technology Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Preclinical CRO Treatment Picture

Figure 2. Global Preclinical CRO Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Preclinical CRO Treatment Market Share by Type: 2024 VS 2031

Figure 4. Bioanalysis and DMPK Studies Features

Figure 5. Toxicology Testing Features

Figure 6. Global Preclinical CRO Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Preclinical CRO Treatment Market Share by Application: 2024 VS 2031

Figure 8. Biopharmaceutical Companies Case Studies

Figure 9. Government and Academic Institutes Case Studies

Figure 10. Medical Device Companies Case Studies

Figure 11. Preclinical CRO Treatment Report Years Considered

Figure 12. Global Preclinical CRO Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Preclinical CRO Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Preclinical CRO Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Preclinical CRO Treatment Market Share by Players in 2024

Figure 16. Global Top Preclinical CRO Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Preclinical CRO Treatment Revenue in 2024

Figure 18. North America Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Preclinical CRO Treatment Market Share by Country (2020-2031)

Figure 20. United States Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Preclinical CRO Treatment Market Share by Country (2020-2031)

Figure 24. Germany Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Preclinical CRO Treatment Market Share by Region (2020-2031)

Figure 32. China Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Preclinical CRO Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Preclinical CRO Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Preclinical CRO Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Charles River Laboratories Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 48. Laboratory Corporation of America Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 49. Envigo Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 50. Eurofins Scientific Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 51. PRA Health Science Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 52. Wuxi Apptec Co.,Ltd. Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 53. Medpace Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 54. Pharmaceutical Product Development Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 55. Paraxel Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 56. Pharmaron Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 57. Joinn Laboratories Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 58. Medicilon Inc. Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 59. Crown Bioscience Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 60. Yinuosi Bio-Technology Revenue Growth Rate in Preclinical CRO Treatment Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global The Contract Research CRO Market Insights Forecast to 2030

Global Contract Research Organization CRO Services Market Insights Forecast to 2030

Global Preclinical Contract Research Organization CRO Market Research Report 2025

Pre Clinical Contract Research Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Development Preclinical CRO Market Research Report 2025

Global Pre Clinical CROs Services Market Research Report 2024

Global Preclinical CRO Services Market Research Report 2024

CROs Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Preclinical Oncology CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CRO Services Market Research Report 2024

Global Healthcare Contract Research Organization Market Insights Forecast to 2030

Clinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Contract Research Organization Solution Market Research Report 2025

Oncology Based Preclinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy CRO Services Market Research Report 2024

Global Oncology Based In vitro CRO Market Research Report 2024

Global CRO Services for BioPharma Market Research Report 2024

Global Cell and Gene Therapy CRO Market Research Report 2024

Global CRO in Clinical Trials Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions